| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KRTAP5-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | FBXO24 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TMEM59L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | METTL10 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | GAB1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TRIM54 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | RP11-637O19.3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TMLHE | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | IL9 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | HSPE1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
